Evaluation of the efficacy, safety and injection interval of intravitreal injection of aflibercept for age-related macular degeneratio
Not Applicable
- Conditions
- age-related macular degeneration
- Registration Number
- JPRN-UMIN000019028
- Lead Sponsor
- Department of Ophthalmology, Shiga University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
severe renal disease unstable angina malignant arrhythmia history of brain infarction history of cerebral hemorrhage severe hypertension
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method change in best-corrected visual acuity (BCVA) from baseline to every visits change in central retinal thickness from baseline to every visits
- Secondary Outcome Measures
Name Time Method rate of adverse events change on fluorescein angiography